Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn

OCT Angiography System

BioPhotonics
Dec 2015
OptovueRequest Info
 
FREMONT, Calif. — Optovue Inc. has announced AngioAnalytics, an angiography quantification system for the detection of eye disease based on optical coherence tomography.

The device quantifies the density of blood flow in the retina, aiding ophthalmologists in detecting and managing eye diseases. Retina changes can be tracked objectively, potentially even before the patient notices significant vision degradation.

The AngioVue imaging system forms detailed 3D images of the retina to visualize anatomic structures and abnormalities as a visual map of blood flow is created. The system is noninvasive and does not require dye injection.


REQUEST INFO ABOUT THIS PRODUCT

* Message:
(requirements, questions for supplier)
Your contact information
* First Name:
* Last Name:
* Email Address:
* Company:
Address:
Address 2:
City:
State/Province:
Postal Code:
* Country:
Phone #:
Fax #:

Register or login to auto-populate this form:
Login Register
* Required

When you click "Send Request", we will record and send your personal contact information to Optovue by email so they may respond directly. You also agree that Photonics Media may contact you with information related to this inquiry, and that you have read and accept our Privacy Policy and Terms and Conditions of Use.
BiophotonicsProductsOptovueAngioAnalyticsAngioVueAmericasOCTangiographyophthalmology

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com
x Subscribe to BioPhotonics magazine - FREE!
X
Are you interested in this product?
When you click "Send Request", we will send the contact details you supply to Optovue so they may respond to your inquiry directly.

Email Address:
Name:
Company:
Stop showing me this for the remainder of my visit